These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1971206)

  • 21. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular mass in borderline hypertension, assessed by echocardiography. Relationships with resting and stress blood pressure.
    Giaconi S; Palombo C; Marabotti C; Genovesi-Ebert A; Mezzasalma L; Volterrani D; Ghione S
    J Nucl Med Allied Sci; 1989; 33(1):26-31. PubMed ID: 2526204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypertensive hypertrophy of the left ventricle: its regression in hypertensive patients with different profiles of plasma renin activity, treated with enalapril].
    Nogueira JB; Soares Ade O; da Costa JN
    Rev Port Cardiol; 1990 Jun; 9(6):511-6. PubMed ID: 2147377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide.
    Idikio H; Fernandez PG; Triggle CR; Kim BK
    Clin Invest Med; 1983; 6(1):43-8. PubMed ID: 6219850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy and tolerability of antihypertensive treatment based on atenolol in the prevention of stroke and the regression of left ventricular hypertrophy.
    Cruickshank JM; Higgins TJ; Pennert K; Thorp JM; Zacharias FM; Zacharias FJ
    J Hum Hypertens; 1987 Sep; 1(2):87-93. PubMed ID: 3506623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regression of cardiac hypertrophy after antihypertensive therapy with nifedipine and captopril.
    Sheiban I; Arcaro G; Covi G; Accardi R; Zenorini C; Lechi A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S187-91. PubMed ID: 2455130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression of cardiac hypertrophy during long term calcium antagonist treatment with tiapamil.
    Ding YA; Huan R; Hsiung MC; Shieh SM
    J Hum Hypertens; 1989 Aug; 3(4):239-43. PubMed ID: 2529374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The regression of left ventricular hypertrophy during the treatment of hypertension with different classes of beta blockers].
    Sirakova V; Penkov N; Kaponov Kh
    Vutr Boles; 1990; 29(6):40-4. PubMed ID: 1982595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of a 2-year examination of patients with essential hypertension and left ventricular hypertrophy].
    Cifková R; Niederle P; Fridl P; Skalická G; Skibová E
    Kardiologiia; 1988 Jan; 28(1):27-30. PubMed ID: 2965771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Lack of association with blood pressure control.
    Fouad FM; Nakashima Y; Tarazi RC; Salcedo EE
    Am J Cardiol; 1982 Mar; 49(4):795-801. PubMed ID: 6461238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular filling pattern in hypertensive patients after reversal of myocardial hypertrophy.
    Agati L; Fedele F; Penco M; Sciomer S; Dagianti A
    Int J Cardiol; 1987 Nov; 17(2):177-85. PubMed ID: 2960623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The correlation of changes in systolic blood pressure with regional anatomical regression of hypertensive left ventricular hypertrophy in patients on chronic antihypertensive therapy (greater than 1 year): alpha-methyldopa compared to propranolol.
    Fernandez PG; Kim BK; Reichek N; Ko P; Gill V; McDonald J; Furlong L; Lewis H; Nolan R; McManamon P
    Curr Med Res Opin; 1984; 8(10):720-33. PubMed ID: 6233093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension.
    Drayer JI; Weber MA; Gardin JM; Lipson JL
    Am J Med; 1983 Sep; 75(3A):116-20. PubMed ID: 6226188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regression of left ventricular hypertrophy during treatment with antihypertensive agents.
    Hill LS; Monaghan M; Richardson PJ
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):255S-260S. PubMed ID: 37879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel therapeutic approach for reversal of left ventricular hypertrophy and blood pressure control in hypertensive patients treated with alpha-methyldopa or propranolol.
    Fernandez PG; Snedden W; Kim BK; Lee CC
    Can J Physiol Pharmacol; 1985 Apr; 63(4):304-8. PubMed ID: 3159468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of captopril on the hypertrophied heart of essential hypertensive patients.
    Furuno Y; Nakashima Y; Fujita M; Sako R; Kuroiwa A
    J UOEH; 1990 Dec; 12(4):379-87. PubMed ID: 2149616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of methyldopa with Pindolol in the treatment of hypertension.
    Szám I; Pálossy B
    Ther Hung; 1979; 27(1):41-5. PubMed ID: 494140
    [No Abstract]   [Full Text] [Related]  

  • 38. The addition of Visken to methyldopa therapy in hypertension: a multicentre study.
    Murphy JE
    J Int Med Res; 1976; 4(2):128-31. PubMed ID: 1026542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Echocardiographic studies of regression of left ventricular hypertrophy in hypertension.
    Fouad-Tarazi FM; Liebson PR
    Hypertension; 1987 Feb; 9(2 Pt 2):II65-8. PubMed ID: 2948912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive effects of pindolol in patients on diuretics.
    Dhatariya RC
    Practitioner; 1977 Apr; 218(1306):570-2. PubMed ID: 859803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.